• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Neurol . Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection - a systemati

tetano

Editor, Senior Moderator
Eur J Neurol


. 2023 Jan 24.
doi: 10.1111/ene.15714. Online ahead of print.
Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection - a systematic review


Diogo Reis Carneiro[SUP] 1 2 [/SUP], Isabel Rocha[SUP] 3 [/SUP], Mario Habek[SUP] 4 5 [/SUP], Raimund Helbok[SUP] 6 [/SUP], Johann Sellner[SUP] 7 8 [/SUP], Walter Struhal[SUP] 9 [/SUP], Gregor Wenning[SUP] 6 [/SUP], Alessandra Fanciulli[SUP] 6 [/SUP]



Affiliations

Abstract

Background: Cardiovascular autonomic dysfunction may reportedly occur after a coronavirus-disease-2019 (COVID-19) infection, but the available evidence is scattered. Here we sought to understand the acute and mid-term effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on cardiovascular autonomic function.
Methods: We performed a systematic PubMed, Embase, Web of Science, medRxiv, and bioRxiv search for cases of cardiovascular autonomic dysfunction during an acute SARS-CoV-2 infection, post-COVID-19 condition. The clinical-demographic characteristics of people in the acute versus post-COVID-19 phase were compared.
Results: We screened 6470 titles and abstracts. Fifty-four full-length articles were included in the data synthesis. One-hundred thirty-four cases were identified: 81 during the acute SARS-CoV-2 infection (24 thereof diagnosed by history), 53 in the post-COVID-19 phase. Post-COVID-19 cases were younger than those with cardiovascular autonomic disturbances in the acute SARS-CoV-2 phase (42 vs. 51-year-old, p=0.002) and were more frequently women (68% vs. 49%, p=0.034). Reflex syncope was the most common cardiovascular autonomic disorder in the acute phase (p=0.008), postural orthostatic tachycardia syndrome (POTS) the most frequent diagnosis in people with post-COVID-19 orthostatic complaints (p<0.001). Full recovery was more frequent in people with acute versus post-COVID-19 onset of cardiovascular autonomic disturbances (43% vs. 15%, p=0.002).
Conclusions: There is evidence from the scientific literature about different types of cardiovascular autonomic dysfunction developing during and after COVID-19. More data about the prevalence of autonomic disorders associated with a SARS-CoV-2 infection are needed to quantify its impact on human health.

Keywords: COVID-19; autonomic nervous system; orthostatic hypotension; postural orthostatic tachycardia syndrome; syncope.
 
Back
Top Bottom